Abstract
Drug chemical manufacturer Carbogen Amcis is adding to its operations in Bubendorf, Switzerland. There the company has agreed to acquire a GEA Pharma Systems site close to its current headquarters. The 3,360-m2 multistory building includes lab, small-scale production, storage, and office space. Carbogen intends to convert more of the facility into regulatory compliant operations for highly potent compound development. The company also plans to add manufacturing of antibody-drug conjugates.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
